Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report.
Kim H, Alshalalfa M, Hoffman-Censits J, Lallas CD, Davicioni E, Lin J, Birbe R, Erho N, Lehrer J, Ashab HA, Takhar M, Olson A, Lam LL, Kelly WK, Knudsen KE, Thangavel C, Seiler R, Feng FY, Schaeffer EM, Trabulsi EJ, Gomella LG, Hurwitz MD, Dicker AP, Den RB. Kim H, et al. Among authors: kelly wk. Urol Case Rep. 2016 Oct 1;9:51-54. doi: 10.1016/j.eucr.2016.08.010. eCollection 2016 Nov. Urol Case Rep. 2016. PMID: 27713863 Free PMC article.
Prostate cancer biomarker: a key field to explore.
Lin J, Yang H, Kelly WK. Lin J, et al. Among authors: kelly wk. Asian J Androl. 2013 May;15(3):358-9. doi: 10.1038/aja.2013.1. Epub 2013 Feb 25. Asian J Androl. 2013. PMID: 23435472 Free PMC article. No abstract available.
Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity.
Plimack ER, Hoffman-Censits JH, Viterbo R, Trabulsi EJ, Ross EA, Greenberg RE, Chen DY, Lallas CD, Wong YN, Lin J, Kutikov A, Dotan E, Brennan TA, Palma N, Dulaimi E, Mehrazin R, Boorjian SA, Kelly WK, Uzzo RG, Hudes GR. Plimack ER, et al. Among authors: kelly wk. J Clin Oncol. 2014 Jun 20;32(18):1895-901. doi: 10.1200/JCO.2013.53.2465. Epub 2014 May 12. J Clin Oncol. 2014. PMID: 24821881 Free PMC article. Clinical Trial.
Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy.
Den RB, Feng FY, Showalter TN, Mishra MV, Trabulsi EJ, Lallas CD, Gomella LG, Kelly WK, Birbe RC, McCue PA, Ghadessi M, Yousefi K, Davicioni E, Knudsen KE, Dicker AP. Den RB, et al. Among authors: kelly wk. Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1038-1046. doi: 10.1016/j.ijrobp.2014.04.052. Epub 2014 Jul 8. Int J Radiat Oncol Biol Phys. 2014. PMID: 25035207 Free PMC article.
Effect of docetaxel on safety and efficacy of radium-223.
Den RB, Kelly WK. Den RB, et al. Among authors: kelly wk. Lancet Oncol. 2014 Nov;15(12):1292-3. doi: 10.1016/S1470-2045(14)71026-5. Epub 2014 Oct 17. Lancet Oncol. 2014. PMID: 25439686 No abstract available.
Novel actions of next-generation taxanes benefit advanced stages of prostate cancer.
de Leeuw R, Berman-Booty LD, Schiewer MJ, Ciment SJ, Den RB, Dicker AP, Kelly WK, Trabulsi EJ, Lallas CD, Gomella LG, Knudsen KE. de Leeuw R, et al. Among authors: kelly wk. Clin Cancer Res. 2015 Feb 15;21(4):795-807. doi: 10.1158/1078-0432.CCR-14-1358. Clin Cancer Res. 2015. PMID: 25691773 Free PMC article.
231 results